Abstract
Levodopa/Carbidopa intestinal gel infusion (LCIG) for Parkinson’s disease is under debate to provoke polyneuropathy (PNP). In our cohort of 20 thus treated patients, two developed debilitating axonal PNP with deficient pyridoxin and folate levels, and marginal cobalamin. Homocysteine was highly elevated. The neuropathies responded to vitamin replacement. We assume that LCIG can provoke PNP most likely of malnutritional origin. To avoid this side effect, the assessment of predisposing factors before treatment as well as neurophysiological and laboratory screenings appear necessary.
This is a preview of subscription content, log in via an institution to check access.
References
Aasheim ET, Hofso D, Hjelmesaeth J, Sandbu R (2008) Peripheral neuropathy and severe malnutrition following duodenal switch. Obes Surg 18:1640–1643
Aita JF, Calame TR (1972) Peripheral neuropathy secondary to isoniazid-induced pyridoxine deficiency. Md State Med J 21:68–70
Antonini A, Isaias IU, Canesi M, Zibetti M, Mancini F, Manfredi L, Dal Fante M, Lopiano L, Pezzoli G (2007) Duodenal levodopa infusion for advanced Parkinson’s disease: 12-month treatment outcome. Mov Disord 22:1145–1149
Dellon AL, Dellon ES, Tassler PL, Ellefson RD, Hendrickson M (2001) Experimental model of pyridoxine (B6) deficiency-induced neuropathy. Ann Plast Surg 47:153–160
Heiser P, Teepker M, Möller JC, Theisen FM, Friedel S, Hebebrand J, Remschmidt H (2004) Neuropathy due to hypovitaminosis following excessive weight loss. J Am Acad Child Adolesc Psychiatry 43:928–929
Juhasz-Pocsine K, Rudnicki SA, Archer RL, Harik SI (2007) Neurologic complications of gastric bypass surgery for morbid obesity. Neurology 68:1843–1850
Manca D, Cossu G, Murgia D, Molari A, Ferrigno P, Marcia E, Melis M (2009) Reversible encephalopathy and axonal neuropathy in parkinson’s disease during duodopa therapy. Mov Disord 24:2293–2294
Müller T, Renger K, Kuhn W (2004) Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration. Arch Neurol 61:657–660
Müller T, Jugel C, Ehret R, Ebersbach G, Bengel G, Muhlack S, Klostermann F (2011) Elevation of total homocysteine levels in patients with Parkinson’s disease treated with duodenal levodopa/carbidopa gel. J Neural Transm (epub ahead of print)
Nyholm D, Nilsson Remahl AI, Dizdar N, Constantinescu R, Holmberg B, Jansson R, Aquilonius SM, Askmark H (2005) Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Neurology 64:216–223
Oertel WH, Wolters E, Sampaio C, Gimenez-Roldan S, Bergamasco B, Dujardin M, Grosset DG, Arnold G, Leenders KL, Hundemer HP, Lledó A, Wood A, Frewer P, Schwarz J (2006) Pergolide versus levodopa monotherapy in early Parkinson’s disease patients: The PELMOPET study. Mov Disord 21:343–353
Saperstein DS, Wolfe GI, Gronseth GS, Nations SP, Herbelin LL, Bryan WW, Barohn RJ (2003) Challenges in the identification of cobalamin-deficiency polyneuropathy. Arch Neurol 60:1296–1301
Thaisetthawatkul P, Collazo-Clavell ML, Sarr MG, Norell JE, Dyck PJ (2004) A controlled study of peripheral neuropathy after bariatric surgery. Neurology 63:1462–1470
Toth C, Brown MS, Furtado S, Suchowersky O, Zochodne D (2008) Neuropathy as a potential complication of levodopa use in Parkinson’s disease. Mov Disord 23:1850–1859
Urban PP, Wellach I, Faiss S, Layer P, Rosenkranz T, Knop K, Weis J (2010) Subacute axonal neuropathy in Parkinson’s disease with cobalamin and vitamin B6 deficiency under duodopa therapy. Mov Disord 25:1748–1752
Weber GA, Sloan P, Davies D (1990) Nutritionally induced peripheral neuropathies. Clin Podiatr Med Surg 7:107–128
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Klostermann, F., Jugel, C., Müller, T. et al. Malnutritional neuropathy under intestinal levodopa infusion. J Neural Transm 119, 369–372 (2012). https://doi.org/10.1007/s00702-011-0689-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-011-0689-3